Skip to main content
. Author manuscript; available in PMC: 2025 Sep 1.
Published in final edited form as: Clin Microbiol Infect. 2024 Jun 7;30(9):1183–1189. doi: 10.1016/j.cmi.2024.06.005

Table 2.

Factors associated with RSV pre-F IgG antibodies according to a generalized linear model.

Characteristics β (95% CI) Fold changes (10β-1, 95% CI) P value

Age group
 4 months to <2 years −1.574 (−1.804, −1.344) −0.973 (−0.984, −0.955) <0.001
 2 to <5 years −0.410 (−0.529, −0.292) −0.611 (−0.704, −0.489) <0.001
 5 to <12 years 0.037 (−0.059, 0.134) 0.090 (−0.127, 0.360) 0.447
 12 to <18 years −0.192 (−0.434, 0.050) −0.357 (−0.632, 0.122) 0.120
 18 to <60 years Reference Reference -
 ≥60 years 0.032 (−0.077, 0.140) 0.076 (−0.162, 0.382) 0.564
Location of residence
 Jiangnan town Reference Reference -
 Tianzhuang town −0.082 (−0.177, 0.013) −0.172 (−0.334, 0.030) 0.090
 Qingtang town −0.296 (−0.394, −0.199) −0.494 (−0.596, −0.367) <0.001
 Heicha School −0.254 (−0.537, 0.029) −0.443 (−0.710, 0.069) 0.079
Household size
 2–4 Reference Reference -
 >4 0.009 (−0.064, 0.081) 0.020 (−0.137, 0.205) 0.815
Underlying diseases
 No Reference Reference -
 Yes 0.096 (−0.013, 0.205) 0.247 (−0.029, 0.602) 0.085

We quantified RSV pre-F IgG antibodies using log10 endpoint titres. β > 0 indicates that the factor was associated with an increase in RSV pre-F IgG antibodies by 10β-1 fold; β < 0 indicates that the factor was associated with a decrease in RSV pre-F IgG antibodies by 1-10β fold.